Received May 15, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA)) | MODERNA | 2 | — | UN / UN |
Hospitalization related to COVID 19 following completion of primary vaccine series
Acute kidney failure (N17.9) o Asthma (J45.909) o Atrial fibrillation (I48.91) o Chronic obstructive pulmonary disease with acute exacerbation (J44.1) o Compression fracture of vertebra (M48.50XA) o Cough (R05) o Depression (F32.9) o Diabetic peripheral neuropathy (E11.42) o Erectile disorder due to medical condition in male patient (N52.1) o Facet arthropathy (M47.819) o Heart failure with preserved ejection fraction (I50.30) o Hyperlipidemia (E78.5) o Hypertension (I10) o Hypokalemia (E87.6) o Iron deficiency anemia (D50.9) o Lower back pain (M54.5) o Normocytic normochromic anemia (D64.9) o Obesity (E66.9) o Obstructive sleep apnea (G47.33) o Osteoarthritis of knee (M17.10) o Osteoporosis (M81.0) o Positive occult stool blood test (R19.5) o Restless legs syndrome (G25.81) o Shortness of breath at rest (R06.02) o Type 2 diabetes mellitus (E11.9) o Urinary hesitancy (R39.11)
Acute kidney failure (N17.9) o Asthma (J45.909) o Atrial fibrillation (I48.91) o Chronic obstructive pulmonary disease with acute exacerbation (J44.1) o Compression fracture of vertebra (M48.50XA) o Cough (R05) o Depression (F32.9) o Diabetic peripheral neuropathy (E11.42) o Erectile disorder due to medical condition in male patient (N52.1) o Facet arthropathy (M47.819) o Heart failure with preserved ejection fraction (I50.30) o Hyperlipidemia (E78.5) o Hypertension (I10) o Hypokalemia (E87.6) o Iron deficiency anemia (D50.9) o Lower back pain (M54.5) o Normocytic normochromic anemia (D64.9) o Obesity (E66.9) o Obstructive sleep apnea (G47.33) o Osteoarthritis of knee (M17.10) o Osteoporosis (M81.0) o Positive occult stool blood test (R19.5) o Restless legs syndrome (G25.81) o Shortness of breath at rest (R06.02) o Type 2 diabetes mellitus (E11.9) o Urinary hesitancy (R39.11)
DULoxetine HCl - 30 MG Oral Capsule TAKE 1 CAPSULE Daily Gabapentin 300 MG Oral CapsuleTAKE 2 CAPSULE THREE TIMES DAILYInjectafer 750 MG/15ML Intravenous SolutionINFUSE 750 MG Intravenous REpeat the dose in 7 xdays.Ipratropium-Albuterol 0
No Known Drug Allergies o No Known Food Allergies o seasonal allergies
Covid positive test date: 4/29/25 and 5/6/25